Adagio Medical Holdings (ADGM) Operating Margin (2023 - 2024)

Adagio Medical Holdings (ADGM) reported Operating Margin of 3352.27% for Q3 2024, up 1879651.0% on a YoY basis from N/an in Q4 2023, and down 27.87% sequentially from 2621.65% in Q2 2024.

Adagio Medical Holdings (ADGM) Operating Margin (2023 - 2024) Analysis & Trends

Adagio Medical Holdings (ADGM) has 2 years of Operating Margin data on file, last reported at 3352.27% in Q3 2024.

  • For the quarter ending Q3 2024, Operating Margin rose 1879651.0% year-over-year to 3352.27%; the trailing twelve-month figure through Dec 2025 stood at 16517.42% (changed N/A YoY), and the FY2024 full-year result was 23226.77%, down 1391277.0% from the prior year.
  • Operating Margin fell to 3352.27% in Q3 2024, from 2621.65% in the prior quarter.
  • In the past five years, Operating Margin ranged from a high of 2621.65% in Q2 2024 to a low of 33903.85% in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Abbott Laboratories 181.51 Bn 174.21 Bn 6.27 Bn 12.05%
2 Stryker 128.52 Bn 125.64 Bn 3.81 Bn 15.55%
3 Medtronic 108.06 Bn 98.84 Bn 6.41 Bn 19.10%
4 Boston Scientific 68.04 Bn 66.59 Bn 3.61 Bn 21.16%
5 Edwards Lifesciences 47.64 Bn 43.97 Bn 1.29 Bn 28.97%
6 GE HealthCare Technologies 28.45 Bn 26.17 Bn 1.98 Bn 10.04%
7 Dexcom 28.41 Bn 27.29 Bn 750.30 Mn 21.42%
8 Smith & Nephew 26.88 Bn 26.30 Bn - -
9 Koninklijke Philips 25.42 Bn 22.29 Bn 2.07 Bn 6.17%
10 Adagio Medical Holdings 22.33 Mn 22.33 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2024 -3,352.27%
Jun 30, 2024 -2,621.65%
Mar 31, 2024 -33,903.85%
Dec 31, 2023 -6,837.18%
Sep 30, 2023 -22,148.78%